SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $27,000 | +12.5% | 105,798 | +1.3% | 0.00% | – |
| Q1 2016 | $24,000 | -85.1% | 104,420 | -77.4% | 0.00% | – |
| Q4 2015 | $161,000 | +109.1% | 461,700 | +926.8% | 0.00% | – |
| Q3 2015 | $77,000 | +60.4% | 44,967 | +105.9% | 0.00% | – |
| Q2 2015 | $48,000 | -91.6% | 21,836 | -92.6% | 0.00% | – |
| Q1 2015 | $573,000 | -42.4% | 295,726 | -21.3% | 0.00% | -100.0% |
| Q4 2014 | $994,000 | -13.0% | 375,726 | -1.1% | 0.00% | 0.0% |
| Q3 2014 | $1,142,000 | -39.9% | 380,056 | -18.3% | 0.00% | 0.0% |
| Q2 2014 | $1,901,000 | -9.5% | 465,237 | -4.6% | 0.00% | 0.0% |
| Q1 2014 | $2,101,000 | -38.5% | 487,875 | -25.2% | 0.00% | -50.0% |
| Q4 2013 | $3,416,000 | -27.4% | 652,298 | -12.6% | 0.00% | -33.3% |
| Q3 2013 | $4,704,000 | – | 746,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |